Mitochondrial Medicine Regional Symposium is organized by United Mitochondrial Disease Foundation (UMDF) and would be held during Oct 13 - 14, 2017 at Akron Children's Hospital: Considine Professional Building, Akron, Ohio, United States of America.
The target audience for this medical event for Neurologists, Geneticists, Researchers/Scientists, Pediatrics, Internal Medicine, Nephrologists, Cardiologists, Endocrinologists, Genetic Counselors, Advanced Practice Nurses, Physicians Assistants, RNs, Occupational Therapy, Physical Therapy and Speech-Language Pathology, Nutritional Therapy, and Residents/Fellows/Students.
Course Description :
The United Mitochondrial Disease Foundation and Children’s Hospital Medical Center of Akron (CHMCA) have joined efforts to sponsor and organize a CME-accredited regional symposium. Mitochondrial diseases are more common than previously recognized and mitochondrial pathophysiology is now a recognized part of many disease processes, including heart disease, cancer, AIDS and diabetes. There have been significant advances in the molecular genetics, proteomics, epidemiology and clinical aspects of mitochondrial pathophysiology. This conference is directed toward the clinician interested in all aspects of mitochondrial medicine. The content of this educational program was determined by rigorous assessment of educational needs and includes surveys, program feedback, expert faculty assessment, literature review, medical practice, and new medical knowledge. The format will include didactic lectures from invited experts. There will be ample time for professional discussion both in and out of the meeting room throughout the meeting. This is a one day meeting aimed at those with clinical interests.
Conference Objectives :
• Explain the basic science of mitochondrial function and how dysfunction can lead to mitochondrial disease.
• Illustrate the symptoms and recognize the “red-flag” symptoms of mitochondrial disease.
• Demonstrate how to begin a mitochondrial evaluations.
• Explain the issue of certainty of diagnosis.
• Explain the basic concepts of primary and secondary mitochondrial disorders.
• Summarize the goals of therapy and to present the current treatments available based on the most recent studies presented in the peer-reviewed medical literature.
• Explain the available diagnostic testing, based on mitochondrial function, and to review new and expanding opportunities including next gen sequencing.
Additional details will be posted as soon as they are available.